Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 3 Issue 7, July 2024

Brain–heart axis

Haykin et al. show that activation of the reward system in the brain modulates adrenergic input to the liver and activation of the complement system, improving cardiac vascularization and recovery after acute myocardial infarction.

See Haykin et al.

Image: Daniel Feyzullayev and Maya Reshef. Cover design: Bethany Vukomanovic

Comment & Opinion

  • The discovery of the genes causing cerebral cavernous malformation (CCM) initially heralded a fruitful search for etiopathogenic molecular pathways in this rare cerebrovascular disease. Recent studies have identified the relevance of CCM proteins for much more common vascular biology and pathologies.

    • Salim Abdelilah-Seyfried
    • Hanjoong Jo
    Comment

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • In response to high fluid shear stress, KLF2-mediated induction of the BMP inhibitor BMPER improves outward arterial remodeling. This knowledge is translated into a preclinical model showing that BMP9 and BMP10 neutralizing antibodies enhance flow recovery and arterialization in ischemia in diabetic mice.

    • Siyu Tian
    • Paul C. Evans
    News & Views
  • Myocardial infarction can damage the heart muscle and lead to heart failure. Research on recovery typically focuses on infiltrating immune cells, damaged cardiomyocytes, over-stimulated fibroblasts and changes in vasculature. Haykin et al. now describe a multi-organ circuit linking these entities, including the brain and liver, in the repair process.

    • Dylan C. Sarver
    • Aldons J. Lusis
    News & Views
  • Myofibroblast activation requires nuclear translocation of ATP citrate lyase (ACLY) that triggers chromatin remodeling and the induction of fibrosis-associated genes. ACLY inhibition prevents myofibroblast conversion and causes de-differentiation of myofibroblasts to fibroblasts, indicating a potential therapeutic approach for heart failure.

    • Nikolaos G. Frangogiannis
    News & Views
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links